Perspective on the Pipeline of Drugs Being Developed With Modulation of DNA Damage as a Target
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-0984
Full Text
Open PDFAbstract
Available in full text
Date
September 7, 2010
Authors
Publisher
American Association for Cancer Research (AACR)